Cannabis is one of the most studied plants of the decade. Treatment-resistant epilepsy, chronic pain, spasticity, anxiety, insomnia, effects on cancer or Parkinson's patients: scientific publications are multiplying, clinical trials are piling up, and regulators are moving forward cautiously.
Since 2015, Newsweed has been tracking all the news at the intersection of cannabis and health: study results, market launches (Sativex, Epidiolex), prescription debates, patient testimonials and scientific controversies. A rigorous, French-language watch for patients, caregivers and the curious.
A new study conducted by Minnesota’s Office of Cannabis Management (OCM) provides one of the most comprehensive datasets to date on the use...
Jamaica is continuing its efforts to integrate small-scale growers into its legal cannabis market. Six years after launching initiatives aimed at...
Bedrocan’s difficulties in the Netherlands could have repercussions beyond the country’s borders. In Denmark, Stenocare is now warning that a disruption in the supply of cannabis products...
A new study conducted on mice suggests that exposure to THC during adolescence may temporarily disrupt the energy metabolism of brain cells, with effects...
The Parliament of the State of New South Wales, in Australia, has passed a law aimed at preventing patients who are legally prescribed...
Yongji Health, a Chinese company that is already a shareholder in Tasmanian Botanics, has completed the acquisition of the shares still held by the Australian producer’s original investors. A transaction worth...
A CBDA-rich cannabis extract has shown promising results in a placebo-controlled clinical trial involving children and adolescents...
Canada, the Netherlands, Italy, Germany, Australia, the United Kingdom… While France is still waiting for general access to medical cannabis to become a reality, many countries have already allowed...
South Korea is preparing to change its approach to medical cannabis. Faced with a rise in the number of patients and the cost of imported treatments,...
While the legalization of cannabis has gradually expanded across the United States, use among teenagers is not following the trajectory feared by some opponents of...
The Danish medical cannabis program saw a sharp increase in usage in 2025, with more than 22,000 prescriptions issued to nearly...
Canopy Growth is now selling its medical cannabis flowers in the United Kingdom. The Canadian producer announced on September 22, 2026, that it would supply four strains...
A ten-year study conducted in Israel suggests that treatment with medical cannabis may be associated with a substantial and lasting reduction in...
After being stalled for a long time in the state legislature, the legalization of cannabis in Wisconsin could gain new momentum in 2027. Democratic Representative Mark Pocan believes that...
Running for several hours doesn't just put a strain on your muscles, heart, or energy reserves. Prolonged exercise is also accompanied by measurable changes in the endocannabinoid system,...
A new study published in *Communications Biology* highlights the role of the CB2 cannabinoid receptor in breast cancer. Rather than simply attempting to...
Following our previous article on the implementing decrees for medical cannabis—which are still stalled at the Ministry of Health—patients are taking the initiative. Fourteen organizations have...
Just as France seemed to be finally moving toward the actual implementation of medical cannabis, the issue appears to have stalled once again....
Effective August 20, 2026, the RIPOST Act introduced a new offense into the Traffic Code: driving after «use...”.
As research on cannabinoids and brain health expands beyond THC and CBD, a much lesser-known molecule is drawing the attention of...
